retatrutide vs semaglutide side effects semaglutide: complete comparison of weight loss, mechanisms, and results Retatrutide UK Guide: Key Facts

Efficacy Results of a SURPASS open-label, phase III trial, published in 2021, demonstrated tirzepatides superior glycaemic efficacy and weight reduction compared with existing GLP-1 receptor agonists, including semaglutide 6

Results At 1 year, patients achieved significant weight loss with a median total weight loss (%TWL) of 25.5% and a median excess weight loss (%EWL) of 66.3% compared to 16.6% and 40.8%, respectively, at treatment initiation with BMI reduction of 3.7 kg/m 2

Clinical trials showed approximately 15% average weight loss over 68 weeks at the 2.4mg weekly dose

It's essential to keep yourself informed about these evolving treatment landscapes to make the best choices for your health

Not everyone needs the maximum 12 mg dose to achieve clinically meaningful weight loss

What phentermine is and how it works Phentermine is old